|
|
Article: International consulting firm Accenture and the US pharma major Bristol-Myers Squibb have collaborated to launch India's first pharmacovigilance centre in Chennai to capture safety data, and the assessment and reporting of that data covering the potential side effects of medicines.(Safety & Environment)(Brief article)
- Article from:
- Chemistry and Industry
- Article date:
- October 8, 2007
- Author:
CopyrightCOPYRIGHT 2007 Society of Chemical Industry. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
International consulting firm Accenture and the US pharma major Bristol-Myers Squibb have collaborated to launch India's first pharmacovigilance centre in Chennai to capture safety data, and the assessment and reporting of that data covering the potential side effects of medicines. The centre will form part of Accenture's ...
Related newspaper, magazine, and journal articles:
|
|
Article: Bristol-Myers Squibb Acquires Novel Oncology Drug ...
PR Newswire;
September 5, 1996 ;
700+ words
... ... Sept. 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY), the Manitoba ... license agreement under which Bristol-Myers Squibb will develop and market DPPE, a novel ... the terms of the agreement, Bristol-Myers Squibb, the world leader in cancer chemotherapy ...
|
|